Back to Search Start Over

1638P Enzalutamide (enza) with or without leuprolide in patients (pts) with high-risk biochemically recurrent (hrBCR) prostate cancer (PC): EMBARK post hoc analysis by age.

Authors :
Shore, N.D.
De Giorgi, U.
Gleave, M.E.
Kalac, M.
Tang, Y.
Croitoru, R.
Rosales, M.
Huynh, M.
Tammela, T.
Jan de Jong, I.
Evans, C.
Carcano, F.M.
Freedland, S.J.
Source :
Annals of Oncology. 2024 Supplement 2, Vol. 35, pS988-S989. 2p.
Publication Year :
2024

Subjects

Subjects :
*LEUPROLIDE
*PROSTATE cancer
*AGE

Details

Language :
English
ISSN :
09237534
Volume :
35
Database :
Academic Search Index
Journal :
Annals of Oncology
Publication Type :
Academic Journal
Accession number :
179693081
Full Text :
https://doi.org/10.1016/j.annonc.2024.08.1719